Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sp-624 (2 trials)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Depressive Disorder, Major (Phase 2)
Schizophrenia (Phase 2)
Trials (2 total)
Trial APIs (1 total)